IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q4 2025 Holdings

Filed 2026-02-13 | 12 holdings | $258.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte Inc(PCVX)COM92243G108$63.3M1,372,42524.5%
Oculis Holding AG(OCS)ORDINARY SHARESH5870P102$45.7M2,288,65817.7%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$39.7M1,366,62415.3%
Evommune Inc(EVMN)COM SHS30054Y107$33.0M1,926,94312.8%
Zenas Biopharma Inc(ZBIO)COM98937L105$21.5M591,9918.3%
Trevi Therapeutics Inc(TRVI)COM89532M101$15.7M1,256,7826.1%
Immunome Inc(IMNM)COM45257U108$15.7M732,5126.1%
Maplight Therapeutics Inc(MPLT)COM56565P103$10.7M611,4474.2%
Bioage Labs Inc(BIOA)COM09077V100$8.6M653,3743.3%
Recursion Pharmaceuticals in(RXRX)CL A75629V104$2.4M595,5180.9%
Rallybio CorpCOM75120L100$1.6M2,404,6440.6%
Bolt Biotherapeutics Inc(BOLT)COM NEW097702203$517.1K94,5730.2%